ArticleFrontiers in pharmacology2023

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma.

Ying He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.